The drug Viagra (sildenafil) has drawn public attention to aphrodisiacs. The search for such substances dates back millennia. Aphrodisiacs can be classified by their mode of action into 3 types: those that increase (1) libido, (2)potency, or (3) sexual pleasure. Various substances of animal and plant origin have been used in folk medicines of different cultures; some have been identified pharmacologically, allowing for under-standing of their mechanisms of action. For increasing libido, ambrein, a major constituent ofAmbra grisea, is used in Arab countries. This tricyclic triterpene alcohol increases the concentration of several anterior pituitary hormones and serum testosterone. Bufo toad skin and glands contain bufotenine (and other bufadienolides), a putative hallucinogenic congener of serotonin. It is the active ingredient in West Indian “love stone” and the Chinese medicationchan su. The aphrodisiac properties are likely of central origin, as are the other effects of the drug. For increasing potency,Panax ginseng, used in traditional Chinese medicine, works as an antioxidant by enhancing nitric oxide synthesis in the endothelium of many organs, including the corpora cavernosa; ginsenosides also enhance acetylcholine-induced and transmural nerve stimulation-activated relaxation associated with increased tissue cyclic guanosine monophosphate, hence the aphrodisiac properties. For increasing sexual pleasure, cantharidin (“Spanish fly”) is a chemical with vesicant properties derived from blister beetles, which have been used for millennia as a sexual stimulant. Its mode of action is by inhibition of phosphodiesterase and protein phosphatase activity and stimulation of β-receptors, inducing vascular congestion and inflammation. Morbidity from its abuse is significant. The ingestion of live beetles (Palembus dermestoides) in Southeast Asia and triatomids in Mexico may have a basis similar to cantharidin. It is of paramount importance for the physician to be aware of the options available to help his or her patients, and to advise them in using the correct drugs while avoiding “miracle” remedies that could be potentially harmful.
aphrodisiac folk medicine Viagra (sildenafil)
This is a preview of subscription content, log in to check access.
Taha SA, Raza M, El-Khawad IE. Effect of ambrein on smooth muscle responses to various agonists.J Ethnopharmacol 1998; 60:19–26.CrossRefPubMedGoogle Scholar
Taha SA, Islam MW, Ageel AM. Effect of ambrein, a major constituent of ambergris, on masculine sexual behavior in rats.Arch Int Pharmacodyn Ther 1995; 329:283–294.PubMedGoogle Scholar
Taha SA. Studies on the mode of action of ambrein as a new antinociceptive compound.Jpn J Pharmacol 1992; 60:67–71.PubMedGoogle Scholar
Islam MW, Tariq M, Ageel AM, et al. Effect ofSalvia haematodes on sexual behaviour of male rats.J Ethnopharmacol 1991; 33:67–72.CrossRefPubMedGoogle Scholar
Ilarionov I. Androgenic and aphrodesiac action of the medicinal plantLithospermum arvense [Bulgarian].Eksp Med Morfol 1989; 28:28–33.PubMedGoogle Scholar
Qureshi S, Shah AH, Tariq M et al. Studies on herbal aphrodisiacs used in Arab system of medicine.Am J Chin Med 1989; 17:57–63.CrossRefPubMedGoogle Scholar
Lyttle T, Goldstein D, Gartz J. Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic.J Psychoactive Drugs 1996; 28:267–290.PubMedGoogle Scholar
Barry TL, Petzinger G, Zito SW. GC/MS comparison of the West Indian aphrodisiac “Love Stone” to the Chinese medication “chan su”: bufotenine and related bufadienolides.J Forensic Sci 1996; 41:1068–1073.PubMedGoogle Scholar
Morton JF. Widespread tannin intake via stimulants and masticatories, especially guarana, kola nut, betel vine, and accessories.Basic Life Sci 1992; 59:739–765.PubMedGoogle Scholar
Jackson G. Sidenafil (Viagra) “reaches the parts other drugs cannot reach.”Int J Clin Pract 1998; 52:359.PubMedGoogle Scholar
Carlson R. Sildenafil: an effective oral drug for impotence.Inpharma 1997; 1085:11–12.Google Scholar
Anonymous. SCRIP World Pharmaceutical News. PJB Publications Ltd, London, UK, May 17, 1996; no. 2129:24.Google Scholar